Expression of inflammatory and insulin signaling genes in adipose tissue in response to elective surgery

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 7, 2010, Pages 3460-3469

  Witasp, Anna ^a   Nordfors, Louise ^a   Schalling, Martin ^a   Nygren, Jonas ^b,c   Ljungqvist, Olle ^a,d   Thorell, Anders ^b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ERSTA HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CD68 ANTIGEN; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ABDOMINAL SURGERY; ADIPOSE TISSUE; ADULT; AGED; ANUS CANCER; ARTICLE; BODY MASS; CLINICAL ARTICLE; COLON CANCER; CROHN DISEASE; DISEASE ASSOCIATION; ELECTIVE SURGERY; ESOPHAGUS CANCER; FEMALE; GASTROINTESTINAL SURGERY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID STORAGE; LIVER METASTASIS; MAJOR SURGERY; MALE; METABOLIC DISORDER; OMENTUM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM CANCER; RNA ANALYSIS; SIGNAL TRANSDUCTION; STOMACH CANCER; SUBCUTANEOUS FAT; SURGICAL INJURY; TRANSCRIPTION REGULATION; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; ENTERITIS; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; AGED; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 77954900627     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2588     Document Type: Article

References (43)

1. Thorell A, Efendic S, Gutniak M, Häggmark T, Ljungqvist O 1993 Development of postoperative insulin resistance is associated with the magnitude of operation. Eur J Surg 159:593-599 (Pubitemid 24002259)
2. Thorell A, Nygren J, Ljungqvist O 1999 Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 2:69-78
3. Thorell A, Loftenius A, Andersson B, Ljungqvist O 1996 Postoperative insulin resistance and circulating concentrations of stress hormones and cytokines. Clin Nutr 15:75-79
4. Thorell A, Efendic S, Gutniak M, Häggmark T, Ljungqvist O 1994 Insulin resistance after abdominal surgery. Br J Surg 81:59-63
5. Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, Haluzikova D, Bosanska L, Vokurka M, Svacina S, Haluzik M 2006 Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 91:4620-4627
6. Gletsu N, Lin E, Zhu JL, Khaitan L, Ramshaw BJ, Farmer PK, Ziegler TR, Papanicolaou DA, Smith CD 2006 Increased plasma interleukin 6 concentrations and exaggerated adipose tissue interleukin 6 content in severely obese patients after operative trauma. Surgery 140:50-57
7. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y 2002 Insulin resistance as an independent predictor of cardiovascular mortality in patients with endstage renal disease. J Am Soc Nephrol 13:1894-1900
8. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM 1995 Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415
9. Dessein PH, Joffe BI, Stanwix AE 2003 Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis. J Rheumatol 30:1403-1405
10. Witasp A, Nordfors L, Schalling M, Nygren J, Ljungqvist O, Thorell A 2009 Increased expression of inflammatory pathway genes in skeletal muscle during surgery. Clin Nutr 28:291-298
11. Felländer G, Nordenström J, Tjäder I, Bolinder J, Arner P 1994 Lipolysis during abdominal surgery. J Clin Endocrinol Metab 78: 150-155
12. Lönnqvist F, Arner P, Nordfors L, Schalling M 1995 Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1:950-953
13. Berg AH, Combs TP, Scherer PE 2002 ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89
14. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW 1997 Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 82:4196-4200
15. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91
16. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I 2005 Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430 (Pubitemid 40139988)
17. Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B 2002 Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87:2084-2089
18. Atzmon G, Yang XM, Muzumdar R, Ma XH, Gabriely I, Barzilai N 2002 Differential gene expression between visceral and subcutaneous fat depots. Horm Metab Res 34:622-628
19. Lassen K, Soop M, Nygren J, Cox PB, Hendry PO, Spies C, von Meyenfeldt MF, Fearon KC, Revhaug A, Norderval S, Ljungqvist O, Lobo DN, Dejong CH; Enhanced Recovery After Surgery (ERAS) Group 2009 Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. Arch Surg 144:961-969
20. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
21. Wellen KE, Hotamisligil GS 2005 Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119
22. Spink J, Cohen J 1997 Synergy and specificity in induction of gene activity by proinflammatory cytokines: potential therapeutic targets. Shock 7:405-412
23. Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, Robb L, Greenhalgh CJ, Förster I, Clausen BE, Nicola NA, Metcalf D, Hilton DJ, Roberts AW, Alexander WS 2003 SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4:540-545
24. Ueki K, Yamamoto-Honda R, Kaburagi Y, Yamauchi T, Tobe K, Burgering BM, Coffer PJ, Komuro I, Akanuma Y, Yazaki Y, Kadowaki T 1998 Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 273:5315-5322
25. Rui L, Yuan M, Frantz D, Shoelson S, White MF 2002 SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277:42394-42398
26. Ghanim H, Aljada A, Daoud N, Deopurkar R, Chaudhuri A, Dandona P 2007 Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia 50:278-285
27. Lin E, Calvano SE, Lowry SF 2000 Inflammatory cytokines and cell response in surgery. Surgery 127:117-126
28. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808
29. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW 2004 Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145:2273-2282
30. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI, DePaoli AM, O'Rahilly S 2002 Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093-1103
31. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A 2004 Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27: 2450-2457
32. Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB 2005 Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 90:4542-4548
33. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ 2006 Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91:295-299
34. Matsuzawa Y 2006 Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3:35-42
35. Dolinková M, Dostálová I, Lacinová Z, Michalský D, Haluzíková D, Mráz M, Kasalický M, Haluzík M 2008 The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol Cell Endocrinol 291:63-70
36. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB 2001 Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729-733
37. Strömmer L, Permert J, Arnelo U, Koehler C, Isaksson B, Larsson J, Lundkvist I, Björnholm M, Kawano Y, Wallberg-Henriksson H, Zierath JR 1998 Skeletal muscle insulin resistance after trauma: insulin signaling and glucose transport. Am J Physiol 275:E351-E358
38. Soop M, Nygren J, Myrenfors P, Thorell A, Ljungqvist O 2001 Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. Am J Physiol Endocrinol Metab 280:E576-E583
39. Nordenström J, Sonnenfeld T, Arner P 1989 Characterization of insulin resistance after surgery. Surgery 105:28-35
40. Dandona P, Chaudhuri A, Ghanim H, Mohanty P 2009 Insulin as an anti-inflammatory and antiatherogenic modulator. J Am Coll Cardiol 53:S14-S20
41. Thorell A, Nygren J, Hirshman MF, Hayashi T, Nair KS, Horton ES, Goodyear LJ, Ljungqvist O 1999 Surgery-induced insulin resistance in human patients: relation to glucose transport and utilization. Am J Physiol 276:E754-E761
42. Makino T, Noguchi Y, Yoshikawa T, Doi C, Nomura K 1998 Circulating interleukin 6 concentrations and insulin resistance in patients with cancer. Br J Surg 85:1658-1662
43. Karmiris K, Koutroubakis IE, Kouroumalis EA 2005 The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease. Inflamm Bowel Dis 11:847-855